Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EFPIA calls for new debate on drug pricing

This article was originally published in SRA

Executive Summary

The research-based pharmaceutical industry is looking at new ways to best characterise the “value for money” offered by their products following the spate of announcements by certain European Union member states of drug price cuts in response to the economic crisis1,2. Vibha Sharma reports from the press conference preceding the 2010 general meeting of European pharmaceutical industry association, EFPIA, held in London from 21-22 June.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS115371

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel